Top Industry Leaders in the Blood Glucose Monitoring Market
Latest Blood Glucose Monitoring Companies Update
Abbott acquires Obsidio: November 2023 acquisition strengthens Abbott's CGM portfolio, expanding their reach and offerings for diabetes management.
Dexcom partners with Ondreon: December 2023 collaboration focuses on developing an integrated diabetes management platform using Dexcom's CGM technology and Ondreon's cloud-based data analytics software.
Roche launches Eversense Continuous Glucose Monitoring System: May 2023 approval in the US offers a long-lasting implanted CGM option for patients with diabetes.
List of Blood Glucose Monitoring Key Companies in the Market
- Abbott Laboratories (US)
- Arkay, Inc. (US)
- Bayer Healthcare AG (Germany)
- Hoffmann-La Roche Ltd (Switzerland)
- Sanofi (France)
- GlySure Ltd (U.K)
- Sphere Medical Holding plc. (UK)
- Dexcom, Inc. (US)and
- LifeScan, Inc. (US)
- Novo Nordisk (Denmark)